We have developed C-STEMTM : a proprietary technology for the mass-production of cell therapies.
A series of proprietary cell therapy programs for co-development or licensing
TreeFrog Therapeutics was selected to join the French Tech 120 ! Launched by the French government, this program dedicated to startups in the hyper-growth phase offers unprecedented support to 123 fast-growing companies. By pooling the skills of numerous government agencies, ministries and public services,......
21 January, 2020 News Video
TreeFrog Therapeutics starts 2020 with a new video, recapitulating the benefits of C-Stem™ to provide access for millions of patients to safe and affordable cell therapies....
08 January, 2020 News Video
Rattaché au directeur financier, et en lien permanent avec l’équipe scientifique, l’assistant(e) Achats et Administration de Treefrog a pour missions de : Appuyer les processus achats de la société : Appui à la gestion de la logistique d’approvisionnements des services R&D et Production (suivi du flux logistique d’approvisionnement, relations fournisseurs) Support global à la fonction administrative (gestion achats administratifs – fournitures, billetterie) Assurer la fonction de réception de la société (standard téléphonique et réception/orientation des visiteurs/livreurs)...
11 December, 2019 JobsI am test text for Image with text shortcode. |
TreeFrog Therapeutics is a stem cell company based in Bordeaux, France, which aims at supporting the advent and industrial development of stem cell therapies. TreeFrog Therapeutics has developed C-Stem, a technology platform to scale-up cell therapy manufacturing. Based on high throughput stem cell encapsulation, C-Stem enables the mass production of human induced pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSCs) in bioreactors, as well as their differentiation into the desired cell type. Founded by Kevin Alessandri and Maxime Feyeux, TreeFrog Therapeutics is a startup company which aims at providing access to cell therapies for all.